Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(16):1226; doi:10.1093/jnci/dji235
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Xu, R.
Right arrow Articles by Gamst, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, R.
Right arrow Articles by Gamst, A.
Related Collections
Right arrowResponse to this Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

CORRESPONDENCE

Re: Lessons from Controversy: Ovarian Cancer Screening and Serum Proteomics

Ronghui Xu, Anthony Gamst

Affiliation of authors: Rebecca and John Moores Cancer Center, Department of Family and Preventive Medicine and Department of Mathematics, University of California, San Diego

Correspondence to: Ronghui Xu, PhD, Moores Cancer Center, 9500 Gilman Dr., Mail Code 0112, La Jolla, CA 92093-0112 (e-mail: rxu@ucsd.edu).

The first 10% of the full text of this article appears below.

We read with interest the paper by Ransohoff (1), which addresses the important issue of validity of published results in "-omics" fields to assess molecular markers for diagnosis and prognosis of cancer. The commentary was directly motivated by the debate around an initial study . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Response to this Correspondence

RESPONSE: Re: Lessons from Controversy: Ovarian Cancer Screening and Serum Proteomics
David F. Ransohoff
J Natl Cancer Inst 2005 97: 1227. [Extract] [Full Text] [PDF]